Recasens A - Search Results

1

DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.

Chen B, McCuaig-Walton D, Tan S, Montgomery AP, Day BW, Kassiou M, Munoz L, Recasens A. Chen B, et al. Among authors: recasens a. Int J Mol Sci. 2021 Apr 13;22(8):4011. doi: 10.3390/ijms22084011. Int J Mol Sci. 2021. PMID: 33924599 Free PMC article.

2

Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells.

Recasens A, Humphrey SJ, Ellis M, Hoque M, Abbassi RH, Chen B, Longworth M, Needham EJ, James DE, Johns TG, Day BW, Kassiou M, Yang P, Munoz L. Recasens A, et al. Cell Death Discov. 2021 Apr 16;7(1):81. doi: 10.1038/s41420-021-00456-6. Cell Death Discov. 2021. PMID: 33863878 Free PMC article.

3

Targeting Cancer Cell Dormancy.

Recasens A, Munoz L. Recasens A, et al. Trends Pharmacol Sci. 2019 Feb;40(2):128-141. doi: 10.1016/j.tips.2018.12.004. Epub 2019 Jan 3. Trends Pharmacol Sci. 2019. PMID: 30612715 Review.

4

Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents.

Abbassi RH, Recasens A, Indurthi DC, Johns TG, Stringer BW, Day BW, Munoz L. Abbassi RH, et al. Among authors: recasens a. ACS Pharmacol Transl Sci. 2019 Jul 30;2(6):402-413. doi: 10.1021/acsptsci.9b00045. eCollection 2019 Dec 13. ACS Pharmacol Transl Sci. 2019. PMID: 32259073 Free PMC article.

5

MerTK activity is not necessary for the proliferation of glioblastoma stem cells.

Hoque M, Wai Wong S, Recasens A, Abbassi R, Nguyen N, Zhang D, Stashko MA, Wang X, Frye S, Day BW, Baell J, Munoz L. Hoque M, et al. Among authors: recasens a. Biochem Pharmacol. 2021 Apr;186:114437. doi: 10.1016/j.bcp.2021.114437. Epub 2021 Feb 8. Biochem Pharmacol. 2021. PMID: 33571503

6

MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells.

Phoa AF, Recasens A, Gurgis FMS, Betts TA, Menezes SV, Chau D, Nordfors K, Haapasalo J, Haapasalo H, Johns TG, Stringer BW, Day BW, Buckland ME, Lalaoui N, Munoz L. Phoa AF, et al. Among authors: recasens a. Cancers (Basel). 2020 Mar 11;12(3):654. doi: 10.3390/cancers12030654. Cancers (Basel). 2020. PMID: 32168910 Free PMC article.

7

Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.

Recasens A, Perier C, Sue CM. Recasens A, et al. Front Mol Neurosci. 2016 Nov 21;9:128. doi: 10.3389/fnmol.2016.00128. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27917109 Free PMC article. Review.

8

In vivo models of alpha-synuclein transmission and propagation.

Recasens A, Ulusoy A, Kahle PJ, Di Monte DA, Dehay B. Recasens A, et al. Cell Tissue Res. 2018 Jul;373(1):183-193. doi: 10.1007/s00441-017-2730-9. Epub 2017 Nov 29. Cell Tissue Res. 2018. PMID: 29185072 Review.

9

Pathogenic lysosomal depletion in Parkinson's disease.

Dehay B, Bové J, Rodríguez-Muela N, Perier C, Recasens A, Boya P, Vila M. Dehay B, et al. Among authors: recasens a. J Neurosci. 2010 Sep 15;30(37):12535-44. doi: 10.1523/JNEUROSCI.1920-10.2010. J Neurosci. 2010. PMID: 20844148 Free PMC article.

10

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M. Recasens A, et al. Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18. Ann Neurol. 2014. PMID: 24243558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page